A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study (Q77853653)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 1999

Language	Label	Description	Also known as
English	A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study	scientific article published on 01 June 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert P Giugliano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

I K Jang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D F Brown

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H V Anderson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Losordo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J C Nicolau

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

O P Dutra

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

O Bazzino

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

V M Viamonte

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Norbady

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A S Liprandi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T J Massey

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Dinsmore

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R P Schwarz

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1879-1885

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10362188%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

TIMI frame count: a quantitative method of assessing coronary artery flow

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The thrombin paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900107-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77853653&oldid=2223810494"